» Articles » PMID: 35326958

Cognitive Impairment in Convalescent COVID-19 Patients Undergoing Multidisciplinary Rehabilitation: The Association with the Clinical and Functional Status

Overview
Specialty Health Services
Date 2022 Mar 25
PMID 35326958
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Cognitive impairment has been reported in the aftermath of severe acute respiratory syndrome due to coronavirus 2 (SARS-CoV-2) infection. We investigated the possible association between cognitive impairment and the main clinical and functional status variables in a cohort of convalescent COVID-19 patients without premorbid diseases potentially affecting cognition.

Methods: We consecutively screened for inclusion of convalescent COVID-19 patients referring to a post-acute care facility for pulmonary rehabilitation. All the enrolled patients were assessed for cognitive functions. We also investigated features of psychological distress (anxiety, depression, symptoms of posttraumatic stress disorder and quality of life) and cardiac and pulmonary functional status.

Results: The 63 enrolled patients (mean age 59.82 ± 10.78, male gender = 47) showed a high frequency of depressive symptoms (76.2%) and anxiety (55.5%), and a high prevalence of symptoms of posttraumatic stress disorder (PTSD, 44.4%). About half of the total sample showed reduced cognitive efficiency (RCE, 44.4%) in the domains of spatial and verbal long-term memory and executive functions. Patients with RCE more frequently showed alteration of blood pressure (BP) circadian rhythm ( = 0.01), higher levels of D-Dimer ( = 0.03), had experienced a severe illness ( = 0.02), had longer disease duration ( = 0.04), more clinically relevant symptoms of PTSD ( = 0.02), more frequent cognitive complaints ( = 0.002), higher anxiety scores ( = 0.01) and lower quality of life ( = 0.02) than patients with normal cognitive efficiency.

Conclusions: Our findings indicated a possible association between the RCE after COVID-19 and some cardiological variables, including some indirect measures of a residual autonomic disorder, such as the presence of an altered BP circadian rhythm. Future research studies with large samples are needed to provide valid conclusions.

Citing Articles

Assessing neurocognitive outcomes in PTSD: a multilevel meta-analytical approach.

Aspelund S, Lorange H, Halldorsdottir T, Baldursdottir B, Valdimarsdottir H, Valdimarsdottir U Eur J Psychotraumatol. 2025; 16(1):2469978.

PMID: 40062977 PMC: 11894747. DOI: 10.1080/20008066.2025.2469978.


Impacts of COVID-19 pandemic prevention measures to the palliative care in Taiwan.

Wu M, Hsiaog S, Huang T, Chu D, Liu C Front Public Health. 2024; 12:1411185.

PMID: 39118972 PMC: 11309006. DOI: 10.3389/fpubh.2024.1411185.


Post-COVID-19 cognitive symptoms in patients assisted by a teleassistance service: a retrospective cohort study.

Bonfim L, Correa T, Freire B, Pedroso T, Pereira D, Fernandes T Front Public Health. 2024; 12:1282067.

PMID: 38689777 PMC: 11060150. DOI: 10.3389/fpubh.2024.1282067.


Pathological Interplay and Clinical Complications between COVID-19 and Cardiovascular Diseases: An Overview in 2023.

Zhou S, Zhang A, Liao H, Liu Z, Yang F Cardiology. 2023; 149(1):60-70.

PMID: 37586358 PMC: 11251668. DOI: 10.1159/000533359.


Cognitive Deficits among Individuals Admitted to a Post-Acute Pneumological Rehabilitation Unit in Southern Italy after COVID-19 Infection.

Lagravinese G, Castellana G, Castellana F, Genco M, Petrelli R, Ruccia M Brain Sci. 2023; 13(1).

PMID: 36672066 PMC: 9857316. DOI: 10.3390/brainsci13010084.


References
1.
Giovagnoli A, Del Pesce M, Mascheroni S, Simoncelli M, Laiacona M, Capitani E . Trail making test: normative values from 287 normal adult controls. Ital J Neurol Sci. 1996; 17(4):305-9. DOI: 10.1007/BF01997792. View

2.
Vandenbroucke J, von Elm E, Altman D, Gotzsche P, Mulrow C, Pocock S . Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Ann Intern Med. 2007; 147(8):W163-94. DOI: 10.7326/0003-4819-147-8-200710160-00010-w1. View

3.
Helms J, Kremer S, Merdji H, Clere-Jehl R, Schenck M, Kummerlen C . Neurologic Features in Severe SARS-CoV-2 Infection. N Engl J Med. 2020; 382(23):2268-2270. PMC: 7179967. DOI: 10.1056/NEJMc2008597. View

4.
Almeria M, Cejudo J, Sotoca J, Deus J, Krupinski J . Cognitive profile following COVID-19 infection: Clinical predictors leading to neuropsychological impairment. Brain Behav Immun Health. 2020; 9:100163. PMC: 7581383. DOI: 10.1016/j.bbih.2020.100163. View

5.
Laszlo G . Standardisation of lung function testing: helpful guidance from the ATS/ERS Task Force. Thorax. 2006; 61(9):744-6. PMC: 2117098. DOI: 10.1136/thx.2006.061648. View